Operaciones Dyadic International, Inc. - DYAI CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.1724 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.030779% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | -0.013666% | ||||||||
Horario tarifa nocturna | 22:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 1.7447 |
Abrir* | 1.7545 |
Cambio de 1 año* | -52.58% |
Rango del día* | 1.7445 - 1.764 |
Rango de 52 semanas | 1.12-4.28 |
Volumen medio (10 días) | 27.01K |
Volumen medio (3 meses) | 1.05M |
Capitalización de mercado | 51.98M |
Ratio P/E | -100.00K |
Acciones en circulación | 28.56M |
Ingresos | 2.50M |
EPS | -0.42 |
Dividendo (Rendimiento %) | N/A |
Beta | 0.59 |
Próxima fecha de resultados | Mar 27, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Feb 2, 2023 | 1.7638 | 0.0093 | 0.53% | 1.7545 | 1.7640 | 1.7445 |
Feb 1, 2023 | 1.7447 | 0.0384 | 2.25% | 1.7063 | 1.7830 | 1.7063 |
Jan 31, 2023 | 1.6965 | 0.0092 | 0.55% | 1.6873 | 1.7640 | 1.6769 |
Jan 30, 2023 | 1.6873 | 0.0098 | 0.58% | 1.6775 | 1.6873 | 1.6384 |
Jan 27, 2023 | 1.6681 | 0.0387 | 2.38% | 1.6294 | 1.6681 | 1.6098 |
Jan 26, 2023 | 1.6394 | 0.0202 | 1.25% | 1.6192 | 1.6394 | 1.6192 |
Jan 25, 2023 | 1.6202 | 0.0590 | 3.78% | 1.5612 | 1.6202 | 1.5612 |
Jan 24, 2023 | 1.6104 | 0.0010 | 0.06% | 1.6094 | 1.6196 | 1.5523 |
Jan 23, 2023 | 1.5527 | 0.1155 | 8.04% | 1.4372 | 1.5625 | 1.4274 |
Jan 20, 2023 | 1.4568 | 0.0392 | 2.77% | 1.4176 | 1.4572 | 1.3890 |
Jan 19, 2023 | 1.4186 | 0.0202 | 1.44% | 1.3984 | 1.4284 | 1.3888 |
Jan 18, 2023 | 1.4090 | -0.1049 | -6.93% | 1.5139 | 1.5239 | 1.3894 |
Jan 17, 2023 | 1.5145 | -0.0190 | -1.24% | 1.5335 | 1.5723 | 1.4949 |
Jan 13, 2023 | 1.5433 | 0.0871 | 5.98% | 1.4562 | 1.5531 | 1.4562 |
Jan 12, 2023 | 1.4186 | 0.0585 | 4.30% | 1.3601 | 1.4186 | 1.3601 |
Jan 11, 2023 | 1.3803 | 0.0106 | 0.77% | 1.3697 | 1.3997 | 1.3603 |
Jan 10, 2023 | 1.3897 | 0.1253 | 9.91% | 1.2644 | 1.3994 | 1.2644 |
Jan 9, 2023 | 1.3038 | -0.0661 | -4.83% | 1.3699 | 1.3899 | 1.2740 |
Jan 6, 2023 | 1.3611 | 0.0865 | 6.79% | 1.2746 | 1.3611 | 1.2746 |
Jan 5, 2023 | 1.2652 | 0.0200 | 1.61% | 1.2452 | 1.2750 | 1.2452 |
Dyadic International, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos totales | 0.59289 | 0.75842 | 1.29545 | 1.68108 | 1.60192 | 2.40383 |
Ingresos | 0.59289 | 0.75842 | 1.29545 | 1.68108 | 1.60192 | 2.40383 |
Coste de los ingresos, total | 0.51616 | 0.6802 | 1.02728 | 1.4597 | 1.42493 | 1.94444 |
Beneficio bruto | 0.07673 | 0.07822 | 0.26817 | 0.22138 | 0.17699 | 0.45939 |
Gastos totales de explotación | 4.44813 | 3.52708 | 8.8879 | 10.9637 | 11.6276 | 17.1313 |
Gastos de venta/general/administración Gastos, total | 4.56212 | 5.03035 | 4.52268 | 5.51992 | 6.0848 | 6.69762 |
Investigación y desarrollo | 0.8856 | 2.2031 | 3.31716 | 3.95632 | 3.86812 | 8.39237 |
Gasto (ingreso) por intereses - Explotación neta | 0.14734 | -0.24906 | 0.02078 | 0.02773 | 0.06235 | 0.09689 |
Gastos (ingresos) extraordinarios | -2.1 | -4.35822 | 0 | |||
Other Operating Expenses, Total | 0.43692 | 0.22072 | 0 | 0.18739 | 0 | |
Ingresos de explotación | -3.85524 | -2.76866 | -7.59245 | -9.28259 | -10.0257 | -14.7275 |
Ingresos por intereses (gastos), netos No operativos | 0.48458 | 0.56615 | 0.89453 | 0.98493 | 0.73171 | 1.65724 |
Ingresos netos antes de impuestos | -3.37067 | -2.20251 | -6.69791 | -8.29766 | -9.29396 | -13.0702 |
Ingresos netos después de impuestos | -3.60874 | -1.33582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Beneficio neto antes de partidas extra. Elementos | -3.60874 | -1.33582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Total de partidas extraordinarias | 0 | -0.8 | ||||
Ingresos netos | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -3.60874 | -1.33582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Beneficio neto diluido | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Promedio ponderado de acciones diluidas | 36.5384 | 28.918 | 27.6733 | 27.0037 | 27.4716 | 27.8381 |
BPA diluido sin partidas extraordinarias | -0.09877 | -0.04619 | -0.20568 | -0.30766 | -0.33945 | -0.46951 |
BPA normalizado diluido | -0.13612 | -0.14415 | -0.20568 | -0.30766 | -0.33945 | -0.46951 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Ingresos totales | 0.46052 | 0.93709 | 0.69293 | 0.31329 | 0.64843 |
Ingresos | 0.46052 | 0.93709 | 0.69293 | 0.31329 | 0.64843 |
Coste de los ingresos, total | 0.39076 | 0.8295 | 0.39254 | 0.33163 | 0.40475 |
Beneficio bruto | 0.06976 | 0.10759 | 0.30039 | -0.01834 | 0.24368 |
Gastos totales de explotación | 3.78114 | 4.80417 | 4.01693 | 4.52908 | 3.39306 |
Gastos de venta/general/administración Gastos, total | 1.55401 | 1.74761 | 1.69284 | 1.70316 | 1.6557 |
Investigación y desarrollo | 1.8081 | 2.20924 | 1.90155 | 2.47348 | 1.34286 |
Gasto (ingreso) por intereses - Explotación neta | 0.02827 | 0.01781 | 0.03 | 0.02081 | -0.01025 |
Ingresos de explotación | -3.32062 | -3.86708 | -3.324 | -4.21579 | -2.74463 |
Ingresos por intereses (gastos), netos No operativos | 0.02567 | 0.0209 | 0.0032 | 1.60746 | 0.00297 |
Ingresos netos antes de impuestos | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Ingresos netos después de impuestos | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Beneficio neto antes de partidas extra. Elementos | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Ingresos netos | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Beneficio neto diluido | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Promedio ponderado de acciones diluidas | 27.5333 | 27.6454 | 28.0792 | 28.0884 | 28.2513 |
BPA diluido sin partidas extraordinarias | -0.11967 | -0.13913 | -0.06109 | -0.15002 | -0.0882 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.11967 | -0.13913 | -0.06109 | -0.15002 | -0.0882 |
Other Operating Expenses, Total | 0 | 0 | 0 | ||
Otros, netos | 1.60553 | -1.60553 | 0.25 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Activo Corriente | 57.6279 | 49.6158 | 42.7481 | 35.6392 | 29.7815 | 21.0083 |
Efectivo e inversiones a corto plazo | 48.9394 | 47.6851 | 41.2028 | 34.2227 | 29.0945 | 20.2603 |
Efectivo y Equivalentes | 6.88936 | 5.78635 | 2.38631 | 4.82354 | 20.6371 | 15.7485 |
Inversiones a corto plazo | 42.05 | 41.8988 | 38.8164 | 29.3992 | 8.45745 | 4.51178 |
Total deudores, neto | 1.08137 | 0.76087 | 1.11985 | 1.31244 | 0.40645 | 0.37221 |
Accounts Receivable - Trade, Net | 0.58821 | 0.27103 | 0.31874 | 0.55853 | 0.2942 | 0.27783 |
Prepaid Expenses | 0.24229 | 1.1698 | 0.42545 | 0.10411 | 0.28056 | 0.37583 |
Other Current Assets, Total | 7.36486 | 0 | ||||
Total Assets | 58.7004 | 50.7442 | 43.3008 | 37.4525 | 30.0724 | 21.2991 |
Long Term Investments | 1.06664 | 0.92265 | 0 | 1.51164 | 0.28471 | 0.28471 |
Other Long Term Assets, Total | 0.00585 | 0.20574 | 0.05214 | 0.05131 | 0.00623 | 0.00612 |
Total Current Liabilities | 1.01024 | 0.7689 | 0.84964 | 1.58803 | 1.62587 | 2.55572 |
Accounts Payable | 0.27906 | 0.52026 | 0.30906 | |||
Accrued Expenses | 0.389 | 0.14796 | 0.39958 | 0.566 | 0.48976 | 0.70956 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.34218 | 0.10068 | 0.141 | 1.02202 | 1.13612 | 1.84616 |
Total Liabilities | 1.01024 | 0.7689 | 0.84964 | 1.58803 | 1.62587 | 2.90866 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Total Equity | 57.6902 | 49.9753 | 42.4512 | 35.8645 | 28.4466 | 18.3905 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | |
Common Stock | 0.03893 | 0.03894 | 0.03897 | 0.03961 | 0.03975 | 0.04048 |
Additional Paid-In Capital | 93.2575 | 93.9136 | 94.3852 | 96.1059 | 98.0131 | 101.026 |
Retained Earnings (Accumulated Deficit) | -25.2043 | -27.3514 | -33.0431 | -41.3511 | -50.6763 | -63.7466 |
Treasury Stock - Common | -10.4019 | -16.6259 | -18.9299 | -18.9299 | -18.9299 | -18.9299 |
Other Equity, Total | 0 | |||||
Total Liabilities & Shareholders’ Equity | 58.7004 | 50.7442 | 43.3008 | 37.4525 | 30.0724 | 21.2991 |
Total Common Shares Outstanding | 32.3823 | 28.3278 | 26.7135 | 27.3592 | 27.4942 | 28.2292 |
Note Receivable - Long Term | 0.50062 | 0.25031 | 0 | |||
Other Liabilities, Total | 0.35294 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 27.9914 | 26.1564 | 23.5722 | 21.0083 | 16.2413 |
Efectivo e inversiones a corto plazo | 27.233 | 25.6007 | 22.7478 | 20.2603 | 15.4401 |
Efectivo y Equivalentes | 13.0556 | 14.0188 | 13.6606 | 15.7485 | 12.419 |
Inversiones a corto plazo | 14.1774 | 11.5819 | 9.0872 | 4.51178 | 3.02106 |
Total deudores, neto | 0.54216 | 0.45475 | 0.25443 | 0.37221 | 0.55705 |
Accounts Receivable - Trade, Net | 0.38496 | 0.29144 | 0.17963 | 0.27783 | 0.52815 |
Prepaid Expenses | 0.21619 | 0.10089 | 0.56997 | 0.37583 | 0.24417 |
Total Assets | 28.2822 | 26.4473 | 23.8631 | 21.2991 | 18.5302 |
Long Term Investments | 0.28471 | 0.28471 | 0.28471 | 0.28471 | 2.28283 |
Other Long Term Assets, Total | 0.00615 | 0.00617 | 0.00614 | 0.00612 | 0.0061 |
Total Current Liabilities | 2.59373 | 3.28849 | 1.96293 | 2.55572 | 1.82648 |
Accrued Expenses | 0.27767 | 0.5948 | 0.84245 | 0.70956 | 0.53301 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.31606 | 2.69368 | 1.12048 | 1.84616 | 1.29347 |
Total Liabilities | 2.59373 | 3.28849 | 1.96293 | 2.90866 | 2.1353 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 25.6885 | 23.1588 | 21.9001 | 18.3905 | 16.3949 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.03981 | 0.04033 | 0.04033 | 0.04048 | 0.04052 |
Additional Paid-In Capital | 98.5499 | 99.8658 | 100.322 | 101.026 | 101.523 |
Retained Earnings (Accumulated Deficit) | -53.9713 | -57.8175 | -59.5327 | -63.7466 | -66.2383 |
Treasury Stock - Common | -18.9299 | -18.9299 | -18.9299 | -18.9299 | -18.9299 |
Total Liabilities & Shareholders’ Equity | 28.2822 | 26.4473 | 23.8631 | 21.2991 | 18.5302 |
Total Common Shares Outstanding | 27.5542 | 28.0792 | 28.0792 | 28.2292 | 28.2642 |
Other Liabilities, Total | 0.35294 | 0.30882 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos netos/Línea de salida | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Efectivo de actividades de explotación | -6.03539 | -1.69117 | -4.40719 | -5.78289 | -6.57439 | -11.2769 |
Partidas no monetarias | 0.26522 | 1.28542 | 1.16463 | 1.39701 | 1.76081 | 0.60508 |
Cash Taxes Paid | 0.0115 | 0.16374 | 0 | -0.50687 | -0.50062 | 0 |
Intereses pagados en efectivo | 0.00091 | |||||
Cambios en el capital circulante | -2.69187 | -0.84078 | 0.11994 | 1.12806 | 0.99008 | 1.18823 |
Efectivo de actividades de inversión | -42.556 | -0.81208 | 3.32832 | 7.70745 | 22.122 | 5.22159 |
Otras partidas de flujo de caja de inversión, total | -42.556 | -0.81208 | 3.32832 | 7.70745 | 22.122 | 5.22159 |
Efectivo procedente de actividades de financiación | -13.1204 | -6.22253 | -2.29954 | 0.55019 | 0.25547 | 1.23005 |
Elementos de flujo de caja de financiación | 0.04063 | |||||
Emisión (retiro) de acciones, neto | -13.161 | -6.22253 | -2.29954 | 0.55019 | 0.25547 | 1.23005 |
Emisión (amortización) de deuda, neta | 0 | |||||
Variación neta de la tesorería | -61.7118 | -8.46787 | -3.40003 | 2.43723 | 15.8135 | -4.88857 |
Efectos del cambio de divisas | 0.25792 | -0.02162 | -0.03752 | 0.01037 | -0.06326 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.29495 | -7.14112 | -8.85639 | -13.0702 | -2.49167 |
Cash From Operating Activities | -1.90651 | -4.30778 | -8.64188 | -11.2769 | -2.85038 |
Non-Cash Items | 0.51329 | 1.07275 | 0.04914 | 0.60508 | 0.45699 |
Changes in Working Capital | 0.87514 | 1.76059 | 0.16537 | 1.18823 | -0.81571 |
Cash From Investing Activities | -5.78394 | -3.28394 | 0.72159 | 5.22159 | -0.52085 |
Other Investing Cash Flow Items, Total | -5.78394 | -3.28394 | 0.72159 | 5.22159 | -0.52085 |
Cash From Financing Activities | 0.1158 | 0.98614 | 0.98555 | 1.23005 | 0.04235 |
Issuance (Retirement) of Stock, Net | 0.1158 | 0.98614 | 0.98555 | 1.23005 | 0.04235 |
Foreign Exchange Effects | -0.00683 | -0.01264 | -0.0417 | -0.06326 | -0.00057 |
Net Change in Cash | -7.58149 | -6.61822 | -6.97643 | -4.88857 | -3.32945 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Emalfarb (Mark A) | Individual Investor | 15.8684 | 4532493 | 138478 | 2023-01-03 | LOW |
Francisco Trust | Corporation | 12.4235 | 3548528 | 0 | 2022-04-14 | LOW |
Bandera Partners LLC | Investment Advisor/Hedge Fund | 5.4858 | 1566908 | 0 | 2022-09-30 | LOW |
Chapin Davis Asset Management | Investment Advisor | 2.8695 | 819629 | 819629 | 2022-12-31 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6382 | 753551 | 0 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.8822 | 251976 | 996 | 2022-09-30 | LOW |
Northeast Financial Consultants Inc | Investment Advisor | 0.8753 | 250000 | 0 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.736 | 210215 | 0 | 2022-09-30 | LOW |
Tarnok (Michael P) | Individual Investor | 0.6614 | 188929 | 0 | 2022-04-14 | LOW |
DIM Funds SICAV S.A. | Hedge Fund | 0.4796 | 137000 | 137000 | 2021-12-31 | |
Sage Mountain Advisors, LLC | Investment Advisor | 0.3731 | 106564 | 0 | 2022-12-31 | MED |
Herbst (Seth J. M.D.) | Individual Investor | 0.3676 | 105000 | 50000 | 2022-04-14 | MED |
Millennium Management LLC | Hedge Fund | 0.3525 | 100674 | -50298 | 2022-09-30 | HIGH |
Rawson (Ping Wang) | Individual Investor | 0.2971 | 84851 | 39351 | 2023-01-03 | LOW |
Hazelton (Joseph P) | Individual Investor | 0.2011 | 57448 | 57448 | 2023-01-03 | |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.198 | 56550 | 0 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.182 | 51974 | 1857 | 2022-09-30 | LOW |
Pekin Hardy Strauss Wealth Management | Investment Advisor | 0.1794 | 51240 | 0 | 2022-09-30 | LOW |
Perkins Capital Management, Inc. | Investment Advisor | 0.1684 | 48100 | 0 | 2022-12-31 | LOW |
Forefront Analytics, LLC | Investment Advisor/Hedge Fund | 0.142 | 40546 | -6225 | 2022-09-30 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com GroupTraders
Clientes activos mensualmente
Volumen mensual de inversión
Retiros por mes
Calculadora de trading
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Dyadic International, Inc. Company profile
Sobre Dyadic International, Inc.
Dyadic International, Inc. es una empresa de plataformas biotecnológicas. La empresa se centra en el desarrollo de la plataforma C1 para su uso en aplicaciones farmacéuticas humanas y animales en todo el mundo. La tecnología de la plataforma C1 se basa en el hongo Myceliopthora thermophila, que la empresa ha denominado C1. La plataforma de expresión génica C1 se utiliza en el descubrimiento, desarrollo y fabricación de medicamentos biológicos y vacunas. La tecnología C1 es un sistema de expresión fúngica para el descubrimiento, desarrollo y producción de enzimas y otras proteínas. La tecnología C1 es una solución comercialmente disponible para captar genes y desarrollar procesos industriales para producir volúmenes de enzimas y otros productos proteicos. La empresa también está trabajando en oportunidades de vacunas y anticuerpos relacionados con COVID-19, incluyendo el candidato a vacuna de COVID-19, DYAI-100.
Industry: | Biotechnology & Medical Research (NEC) |
140 Intracoastal Pointe Dr Ste 404
JUPITER
FLORIDA 33477
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 485.000 traders de todo el mundo que eligen operar con Capital.com